04.01.2019 NL law General Court leaves door ajar for pharma companies in the Servier-case Short Reads - On 12 December 2018, the General Court partly annulled the Commission's decision to fine drug manufacturer and originator company Servier and five generic companies in a reverse payment patent settlement case. Read more Team: Floris ten Have, Daria Budurca